Biopalette
About:
Biopalette is a operator of a platform intended to offer gene-editing techniques.
Website: http://biopalette.co.jp
Top Investors: F-Prime Capital, ARCH Venture Partners, Eight Roads Ventures, JAFCO, Eight Roads Ventures Japan
Description:
Biopalette is a operator of a platform intended to offer gene-editing techniques. Bio Palette plans to develop our business in three fields, classified based on the type of cells targeted for genome editing.
Total Funding Amount:
$18.3M
Estimated Revenue Range:
$1M to $10M
Headquarters Location:
Kobe, Kyoto, Japan
Founded Date:
2017-02-21
Founders:
Shinichi Fuki
Number of Employees:
11-50
Last Funding Date:
2020-09-24
IPO Status:
Private
Industries:
© 2025 bioDAO.ai